3Pramoolsinsup C.Management of viral hepatitis B.J Gastroenterol Hepatol,2002,17 Suppl:S125-145.
4Fontana RJ,Hann HW,Perrilio RP.et a1.Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy.Gastroenterology,2002,123:719-727.
5Lindsay KL.Introduction to therapy and hepatitis C.Hepatology,2002,36(Suppl):S114-120,S121-127.S135-144.
6Mast EE, Alter MJ. Epidemiology of viral hepatitis: an overview.Semin Virol, 1993,4:273-283.
7Lai CL, Chien RN, Leung NWY, et al. A one-year trial of lamivudine for chronic hepatitis B. NEJM, 1998,339:61-68.
8Kobayashi Satsuki, Ide Tatsuya, Sata Miehio, et al. Detection of YMDD motif mutations in some lamivudine~untreated asymptomatic hepatitis B virus carriers. J Hepatol, 2001,34 : 584-586.
9Kirishima Toshihiko, Okanoue Takeshi, Daimon Yukiko, et al.Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment. J Hepatol, 2002, 37: 259-265.
4Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
7Leung N ,Gish RG,Wang C, et al. A randomized,double-blind comparison of 3 doses of emtricitabine in patients with chronic hepatitis B given 48 weeks of treatment[J]. Hepatology, 2001, 34(Suppl) : 349A.
8Gish R, Leung N, Wang C, et al. Antiviral activity,safety, andincidence of resistance in chronically infected hepatitis B patients (CHB) given once daily emtricitabine for 2 years [J].Hepatology, 2002,36 (Suppl):372 A.
9Lai CL, Leung NWY , Teo EK , et al. Results of a one-year international phase IIB comparative trial of telbivudine,lamivudine, and the combination in patients with chronic hepatitis B [J]. Hepatology, 2003,38(Suppl):262 A.
10van Bommel F, Wunsche T, Schurmann D, et al. A comparision of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus (HBV) infection[J]. Hepatology, 2003,38(Suppl): 275 A.